Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
CONCLUSIONS: Use of anakinra reduced attack frequency and proteinuria and acute-phase reactant levels, and improved QoL, with only a few uncomplicated side effects among colchicine-resistant or intolerant FMF patients. Injection-site reactions of severity insufficient to require discontinuation of treatment were seen.
PMID: 31116269 [PubMed - in process]
Source: Sao Paulo Medical Journal - Category: General Medicine Authors: Sargin G, Kose R, Senturk T Tags: Sao Paulo Med J Source Type: research
More News: Amyloidosis | Colchicine | Colcrys | Databases & Libraries | General Medicine | Laboratory Medicine | Men | Middle East Health | Proteinuria | Rheumatology | Statistics | Study | Toxicology | Turkey Health